Time-course proteome analysis reveals the dynamic response of cryptococcus gattii cells to fluconazole

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Chong, Hin Siong ^a   Campbell, Leona ^a   Padula, Matthew P ^b   Hill, Cameron ^c   Harry, Elizabeth ^b   Li, Simone S ^d   Wilkins, Marc R ^d   Herbert, Ben ^c   Carter, Dee ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; FLUCONAZOLE; PROTEOME; RIBOSOME PROTEIN;

ANTIFUNGAL ACTIVITY; ARTICLE; CELL VIABILITY; CRYPTOCOCCUS GATTII; DRUG RESPONSE; FUNGAL CELL; FUNGUS GROWTH; NONHUMAN; PROTEIN ANALYSIS; RESPIRATORY CHAIN; RIBOSOME;

ANTIFUNGAL AGENTS; CRYPTOCOCCUS GATTII; FLUCONAZOLE; FUNGAL PROTEINS; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; TIME FACTORS;

ANIMALIA; CRYPTOCOCCUS GATTII; FUNGI;

EID: 84864669507     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042835     Document Type: Article

References (76)

1. Byrnes EJ 3rd, Li W, Lewit Y, Ma H, Voelz K, et al. ((2010)) Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathogens 6: e1000850.
2. Harun A, Gilgado F, Chen SC, Meyer W, ((2010)) Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonization of airways in cystic fibrosis. Medical Mycology 48 Suppl 1: S70-76.
3. Bartlett K, Fyfe MW, MacDougall LA, ((2003)) Environmental Cryptococcus neoformans var. gattii in British Colombia, Canada. American Journal of Respiratory and Critical Care Medicine 167: A499.
4. Kontoyiannis DP, Lewis RE, ((2002)) Antifungal drug resistance of pathogenic fungi. Lancet 359: 1135-1144.
5. Pfaller MA, Marco F, Messer SA, Jones RN, ((1998)) In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis 30: 251-255.
6. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, et al. ((2009)) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. Aids 23: 525-530.
7. Chong HS, Dagg R, Malik R, Chen S, Carter D, ((2010)) In vitro susceptibility of the yeast pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype. Journal of Clinical Microbiology 48: 4115-4120.
8. Iqbal N, DeBess EE, Wohrle R, Sun B, Nett RJ, et al. ((2010)) Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. Journal of Clinical Microbiology 48: 539-544.
9. Rogers PD, Vermitsky JP, Edlind TD, Hilliard GM, ((2006)) Proteomic analysis of experimentally induced azole resistance in Candida glabrata. J Antimicrob Chemother 58: 434-438.
10. Hoehamer CF, Cummings ED, Hilliard GM, Rogers PD, ((2010)) Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents. Antimicrobial Agents and Chemotherapy 54: 1655-1664.
11. Yu H, Braun P, Yildirim MA, Lemmens I, Venkatesan K, et al. ((2008)) High-quality binary protein interaction map of the yeast interactome network. Science 322: 104-110.
12. Bertin N, Simonis N, Dupuy D, Cusick ME, Han JD, et al. ((2007)) Confirmation of organized modularity in the yeast interactome. PLoS Biology 5: e153.
13. Nakamoto RK, Ketchum CJ, al-Shawi MK, ((1999)) Rotational coupling in the F0F1 ATP synthase. Annual Review of Biophysics and Biomolecular Structure 28: 205-234.
14. Wang H, Oster G, ((1998)) Energy transduction in the F1 motor of ATP synthase. Nature 396: 279-282.
15. Okuno D, Iino R, Noji H, ((2011)) Rotation and structure of FoF1-ATP synthase. J Biochem 149: 655-664.
16. Del Sorbo G, Schoonbeek H, De Waard MA, ((2000)) Fungal transporters involved in efflux of natural toxic compounds and fungicides. Fungal Genetics and Biology 30: 1-15.
17. Parkinson T, Falconer DJ, Hitchcock CA, ((1995)) Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrobial Agents and Chemotherapy 39: 1696-1699.
18. Voit EO, ((2003)) Biochemical and genomic regulation of the trehalose cycle in yeast: review of observations and canonical model analysis. Journal of Theoretical Biology 223: 55-78.
19. Mahmud SA, Hirasawa T, Shimizu H, ((2010)) Differential importance of trehalose accumulation in Saccharomyces cerevisiae in response to various environmental stresses. Journal of Bioscience and Bioengineering 109: 262-266.
20. Mukhopadhyay K, Prasad T, Saini P, Pucadyil TJ, Chattopadhyay A, et al. ((2004)) Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans. Antimicrobial Agents and Chemotherapy 48: 1778-1787.
21. Veen M, Lang C, ((2005)) Interactions of the ergosterol biosynthetic pathway with other lipid pathways. Biochemical Society Transactions 33: 1178-1181.
22. Florio AR, Ferrari S, De Carolis E, Torelli R, Fadda G, et al. ((2011)) Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A. BMC Microbiology 11: 97.
23. Manavathu EK, Cutright JL, Chandrasekar PH, ((1998)) Organism-dependent fungicidal activities of azoles. Antimicrob Agents Chemother 42: 3018-3021.
24. Brummer E, Kamei K, Miyaji M, ((1998)) Damage to yeast cells of Cryptococcus neoformans by voriconazole and fluconazole: a culture and microscopic study. Medical Mycology 36: 227-233.
25. Sionov E, Lee H, Chang YC, Kwon-Chung KJ, ((2010)) Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathogens 6: e1000848.
26. Gautam P, Shankar J, Madan T, Sirdeshmukh R, Sundaram CS, et al. ((2008)) Proteomic and transcriptomic analysis of Aspergillus fumigatus on exposure to amphotericin B. Antimicrobial Agents and Chemotherapy 52: 4220-4227.
27. Lepak A, Nett J, Lincoln L, Marchillo K, Andes D, ((2006)) Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole. Antimicrobial Agents and Chemotherapy 50: 1311-1319.
28. Synetos D, Dabeva MD, Warner JR, ((1992)) The yeast ribosomal protein S7 and its genes. Journal of Biological Chemistry 267: 3008-3013.
29. Palmer DA, Thompson JK, Li L, Prat A, Wang P, ((2006)) Gib2, a novel Gbeta-like/RACK1 homolog, functions as a Gbeta subunit in cAMP signaling and is essential in Cryptococcus neoformans. Journal of Biological Chemistry 281: 32596-32605.
30. Abe F, Hiraki T, ((2009)) Mechanistic role of ergosterol in membrane rigidity and cycloheximide resistance in Saccharomyces cerevisiae. Biochimica et Biophysica Acta 1788: 743-752.
31. Cognetti D, Davis D, Sturtevant J, ((2002)) The Candida albicans 14-3-3 gene, BMH1, is essential for growth. Yeast 19: 55-67.
32. Roberts RL, Mosch HU, Fink GR, ((1997)) 14-3-3 proteins are essential for RAS/MAPK cascade signaling during pseudohyphal development in S. cerevisiae. Cell 89: 1055-1065.
33. Bertram PG, Zeng C, Thorson J, Shaw AS, Zheng XF, ((1998)) The 14-3-3 proteins positively regulate rapamycin-sensitive signaling. Current Biology 8: 1259-1267.
34. Jobbins SE, Hill CJ, D'Souza-Basseal JM, Padula MP, Herbert BR, et al. ((2010)) Immunoproteomic approach to elucidating the pathogenesis of cryptococcosis caused by Cryptococcus gattii. Journal of Proteome Research 9: 3832-3841.
35. Steen BR, Zuyderduyn S, Toffaletti DL, Marra M, Jones SJ, et al. ((2003)) Cryptococcus neoformans gene expression during experimental cryptococcal meningitis. Eukaryotic Cell 2: 1336-1349.
36. Snyder SH, Verma A, Trifiletti RR, ((1987)) The peripheral-type benzodiazepine receptor: a protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands. FASEB Journal 1: 282-288.
37. Li H, Papadopoulos V, ((1998)) Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139: 4991-4997.
38. Frank W, Baar KM, Qudeimat E, Woriedh M, Alawady A, et al. ((2007)) A mitochondrial protein homologous to the mammalian peripheral-type benzodiazepine receptor is essential for stress adaptation in plants. Plant Journal 51: 1004-1018.
39. Nailis H, Vandenbosch D, Deforce D, Nelis HJ, Coenye T, ((2010)) Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms. Research in Microbiology 161: 284-292.
40. Agarwal AK, Rogers PD, Baerson SR, Jacob MR, Barker KS, et al. ((2003)) Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. Journal of Biological Chemistry 278: 34998-35015.
41. Bledi Y, Inberg A, Linial M, ((2003)) PROCEED: A proteomic method for analysing plasma membrane proteins in living mammalian cells. Brief Funct Genomic Proteomic 2: 254-265.
42. Pedersen SK, Harry JL, Sebastian L, Baker J, Traini MD, et al. ((2003)) Unseen proteome: mining below the tip of the iceberg to find low abundance and membrane proteins. Journal of Proteome Research 2: 303-311.
43. Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, et al. ((2004)) Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430: 88-93.
44. Hsing M, Byler KG, Cherkasov A, ((2008)) The use of Gene Ontology terms for predicting highly-connected 'hub' nodes in protein-protein interaction networks. BMC Syst Biol 2: 80.
45. Hwang YC, Lin CC, Chang JY, Mori H, Juan HF, et al. ((2009)) Predicting essential genes based on network and sequence analysis. Molecular BioSystems 5: 1672-1678.
46. Cruz MC, Goldstein AL, Blankenship JR, Del Poeta M, Davis D, et al. ((2002)) Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO Journal 21: 546-559.
47. Edlind T, Smith L, Henry K, Katiyar S, Nickels J, ((2002)) Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling. Molecular Microbiology 46: 257-268.
48. Marchetti O, Moreillon P, Glauser MP, Bille J, Sanglard D, ((2000)) Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrobial Agents and Chemotherapy 44: 2373-2381.
49. Heo JM, Livnat-Levanon N, Taylor EB, Jones KT, Dephoure N, et al. ((2010)) A stress-responsive system for mitochondrial protein degradation. Molecular Cell 40: 465-480.
50. Braun RJ, Zischka H, ((2008)) Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human disease. Biochimica et Biophysica Acta 1783: 1418-1435.
51. Noguchi M, Takata T, Kimura Y, Manno A, Murakami K, et al. ((2005)) ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif. Journal of Biological Chemistry 280: 41332-41341.
52. Craig EA, Marszalek J, ((2002)) A specialized mitochondrial molecular chaperone system: a role in formation of Fe/S centers. Cellular and Molecular Life Sciences 59: 1658-1665.
53. Liu Q, D'Silva P, Walter W, Marszalek J, Craig EA, ((2003)) Regulated cycling of mitochondrial Hsp70 at the protein import channel. Science 300: 139-141.
54. Horst M, Oppliger W, Rospert S, Schonfeld HJ, Schatz G, et al. ((1997)) Sequential action of two hsp70 complexes during protein import into mitochondria. EMBO Journal 16: 1842-1849.
55. Craig EA, Kramer J, Kosic-Smithers J, ((1987)) SSC1, a member of the 70-kDa heat shock protein multigene family of Saccharomyces cerevisiae, is essential for growth. Proceedings of the National Academy of Sciences of the United States of America 84: 4156-4160.
56. Kawai A, Nishikawa S, Hirata A, Endo T, ((2001)) Loss of the mitochondrial Hsp70 functions causes aggregation of mitochondria in yeast cells. Journal of Cell Science 114: 3565-3574.
57. Breslow DK, Cameron DM, Collins SR, Schuldiner M, Stewart-Ornstein J, et al. ((2008)) A comprehensive strategy enabling high-resolution functional analysis of the yeast genome. Nature Methods 5: 711-718.
58. Roy J, Zheng B, Rymond BC, Woolford JL Jr, ((1995)) Structurally related but functionally distinct yeast Sm D core small nuclear ribonucleoprotein particle proteins. Molecular and Cellular Biology 15: 445-455.
59. Camasses A, Bragado-Nilsson E, Martin R, Seraphin B, Bordonne R, ((1998)) Interactions within the yeast Sm core complex: from proteins to amino acids. Molecular and Cellular Biology 18: 1956-1966.
60. Tabb MM, Tongaonkar P, Vu L, Nomura M, ((2000)) Evidence for separable functions of Srp1p, the yeast homolog of importin alpha (Karyopherin alpha): role for Srp1p and Sts1p in protein degradation. Molecular and Cellular Biology 20: 6062-6073.
61. Ryan KJ, Zhou Y, Wente SR, ((2007)) The karyopherin Kap95 regulates nuclear pore complex assembly into intact nuclear envelopes in vivo. Molecular Biology of the Cell 18: 886-898.
62. Kaffman A, Rank NM, O'Shea EK, ((1998)) Phosphorylation regulates association of the transcription factor Pho4 with its import receptor Pse1/Kap121. Genes & Development 12: 2673-2683.
63. Taberner FJ, Igual JC, ((2010)) Yeast karyopherin Kap95 is required for cell cycle progression at Start. BMC Cell Biology 11: 47.
64. Mendenhall MD, Hodge AE, ((1998)) Regulation of Cdc28 cyclin-dependent protein kinase activity during the cell cycle of the yeast Saccharomyces cerevisiae. Microbiology and Molecular Biology Reviews 62: 1191-1243.
65. Lew DJ, Reed SI, ((1993)) Morphogenesis in the yeast cell cycle: regulation by Cdc28 and cyclins. Journal of Cell Biology 120: 1305-1320.
66. Dieckhoff P, Bolte M, Sancak Y, Braus GH, Irniger S, ((2004)) Smt3/SUMO and Ubc9 are required for efficient APC/C-mediated proteolysis in budding yeast. Molecular Microbiology 51: 1375-1387.
67. Takahashi Y, Iwase M, Konishi M, Tanaka M, Toh-e A, et al. ((1999)) Smt3, a SUMO-1 homolog, is conjugated to Cdc3, a component of septin rings at the mother-bud neck in budding yeast. Biochemical and Biophysical Research Communications 259: 582-587.
68. Biggins S, Bhalla N, Chang A, Smith DL, Murray AW, ((2001)) Genes involved in sister chromatid separation and segregation in the budding yeast Saccharomyces cerevisiae. Genetics 159: 453-470.
69. Fabre E, Hurt E, ((1997)) Yeast genetics to dissect the nuclear pore complex and nucleocytoplasmic trafficking. Annual Review of Genetics 31: 277-313.
70. Bucci M, Wente SR, ((1998)) A novel fluorescence-based genetic strategy identifies mutants of Saccharomyces cerevisiae defective for nuclear pore complex assembly. Molecular Biology of the Cell 9: 2439-2461.
71. Bogerd AM, Hoffman JA, Amberg DC, Fink GR, Davis LI, ((1994)) nup1 mutants exhibit pleiotropic defects in nuclear pore complex function. Journal of Cell Biology 127: 319-332.
72. Nesvizhskii AI, Keller A, Kolker E, Aebersold R, ((2003)) A statistical model for identifying proteins by tandem mass spectrometry. Analytical Chemistry 75: 4646-4658.
73. Keller A, Nesvizhskii AI, Kolker E, Aebersold R, ((2002)) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Analytical Chemistry 74: 5383-5392.
74. Zybailov BL, Florens L, Washburn MP, ((2007)) Quantitative shotgun proteomics using a protease with broad specificity and normalized spectral abundance factors. Molecular BioSystems 3: 354-360.
75. Ho E, Webber R, Wilkins MR, ((2008)) Interactive three-dimensional visualization and contextual analysis of protein interaction networks. Journal of Proteome Research 7: 104-112.
76. Cohen-Gihon I, Sharan R, Nussinov R, ((2011)) Processes of fungal proteome evolution and gain of function: gene duplication and domain rearrangement. Physical Biology 8: 035009.